Tag

#Diversified Pharmaceuticals (TRBC)

Home » Diversified Pharmaceuticals (TRBC)

34 posts
Bookmark?Remove?

EU regulators charge Teva over pay-for-delay drug deal

A building belonging to Teva Pharmaceutical Industries, the world’s biggest generic drugmaker and Israel’s largest company, is seen in Jerusalem February 8, 2017. EU antitrust regulators charged Israeli drugmaker Teva (TEVA.TA) (TEVA.N) on Monday with doing an... More »

Bookmark?Remove?

Lupin sets off down Indian pharma`s long road to redemption

An employee inspects tablets as they move along the production line at a pharmaceutical plant of Lupin, India’s No. 2 drugmaker, in Verna, in the western state of Goa, India, June 9, 2017. Picture taken June 9, 2017. REUTERS/Danish Siddiqui In 28 years in Indi... More »

Bookmark?Remove?

Trump reaches out to lawmakers on healthcare as another says `no`

U.S. President Donald Trump delivers remarks as he hosts a Congressional picnic event, accompanied by First Lady Melania Trump, at the White House in Washington, U.S., June 22, 2017. REUTERS/Carlos Barria President Donald Trump made calls to fellow Republicans... More »

Bookmark?Remove?

Scientists to test whether Zika can kill brain cancer cells

FILE PHOTO – Genetically modified male Aedes aegypti mosquitoes are pictured at Oxitec factory in Piracicaba, Brazil, October 26, 2016. REUTERS/Paulo Whitaker Scientists in Britain plan to harness the Zika virus to try to kill brain tumor cells in experiments ... More »

Bookmark?Remove?

Bristol-Myers NASH drug reduces liver fat in midstage study

Bristol-Myers Squibb Co said its lead experimental drug for nonalcoholic steatohepatitis, or NASH, significantly reduced liver fat versus placebo, according to data from a mid-stage trial presented at a medical meeting on Saturday. More »

Bookmark?Remove?

U.S.-UK alliance targets the world`s deadliest superbugs

MRSA (Methicillin-resistant Staphylococcus aureus) bacteria strain is seen in a petri dish containing agar jelly for bacterial culture in a microbiological laboratory in Berlin March 1, 2008. MRSA is a drug-resistant ”superbug”, which can cause deadly infectio... More »

Bookmark?Remove?

ValueAct boosts Valeant stake after Pershing exits

FILE PHOTO – A sign for the headquarters of Valeant Pharmaceuticals International Inc is seen in Laval, Quebec June 14, 2016. REUTERS/Christinne Muschi/File Photo ValueAct Capital raised its stake in Valeant Pharmaceuticals International Inc, in a move that co... More »

Bookmark?Remove?

Anthem sues Cigna to block deal termination

FILE PHOTO — A sign at the office building of health insurer Anthem is seen in Los Angeles, California February 5, 2015. REUTERS/Gus Ruelas/File Photo Anthem Inc said on Wednesday it has filed a lawsuit seeking to block smaller rival Cigna Corp from terminatin... More »

Bookmark?Remove?

Marathon pauses Duchenne drug launch amid price outcry

Marathon Pharmaceuticals LLC said on Monday it was “pausing” the launch of its Duchenne muscular dystrophy drug after U.S. lawmakers questioned why the company priced it at $89,000 a year when patients had been able to import it for as little as $1,000. More »

Bookmark?Remove?

U.S. House speaker says Obamacare replacement will pass this year

U.S. House Speaker Paul Ryan arrives on stage before President Donald Trump speaks during the 2017 ”Congress of Tomorrow” Joint Republican Issues Conference in Philadelphia, Pennsylvania, U.S. January 26, 2017. REUTERS/Mark Makela The U.S. House of Representat... More »

U.S. health spending in 2015 rose at fastest rate since 2007

A person holds pharmaceutical tablets and capsules in this picture illustration taken in Ljubljana September 18, 2013. REUTERS/Srdjan Zivulovic U.S. health spending in 2015 rose at its fastest rate since 2007, driven by expanded access to insurance under the A... More »

Bookmark?Remove?

U.S. hedge fund files lawsuit accusing Theranos of fraud

A San Francisco-based hedge fund has filed a lawsuit against Theranos Inc, accusing the blood testing company of using fraudulent methods to attract an investment of nearly $100 million, according to an investor letter filed by the fund. More »

Bookmark?Remove?

Endo International CEO steps down, Campanelli named successor

Endo International Plc (ENDP.O) said Chief Executive Rajiv De Silva had stepped down and would be replaced by generics division head Paul Campanelli, as the drugmaker grapples with a large debt load and mounting pressure on some of its drug prices. More »

Valeant says discount program for heart drugs on track

A sign for the headquarters of Valeant Pharmaceuticals International Inc is seen in Laval, Quebec June 14, 2016. REUTERS/Christinne Muschi Valeant Pharmaceuticals International Inc said its discount and rebates program for two high-priced heart drugs would cov... More »

Consumer groups press Yum’s KFC to tighten antibiotic rules

LOS ANGELES Consumer groups will deliver a petition from more than 350,000 people to the KFC restaurant chain on Wednesday, calling on the Yum Brands Inc unit (YUM.N) to stop the routine use of antibiotics by the companies that supply its chicken. Several fast... More »

Teva’s opioid not abuse-deterrent when taken orally: FDA staff

An experimental, long-acting painkiller made by Teva Pharmaceutical Industries Ltd does not have abuse-resistant properties when taken orally, according to a preliminary review by the U.S. Food and Drug Administration. The drug, whose proposed trade name is Va... More »

FDA staff posts voting questions for Teva’s opioid painkiller

U.S. Food and Drug Administration staff released voting questions on Teva Pharmaceutical Industries Ltd’s long-acting opioid painkiller for a panel of independent experts who will recommend to the agency whether to approve the drug. An FDA spokesman on Friday ... More »

Valeant to provide rebate programs for two heart drugs

Valeant Pharmaceuticals International Inc said on Monday it would make available to all hospitals in the United States an enhanced rebate program to reduce the price of its heart drugs Nitropress and Isuprel. All hospitals are eligible for a rebate of at least... More »

FDA clears J&J’s chemotherapy for certain soft tissue sarcomas

The U.S. Food and Drug Administration said it approved Johnson & Johnson’s chemotherapy to treat specific soft-tissue sarcomas (STS) that have spread to other parts of the body or cannot be removed by surgery. The drug, Yondelis, is designed to delay the progr... More »

FDA expands approval of Merck’s Keytruda to lung cancer

The U.S. Food and Drug Administration on Friday approved Merck & Co Inc’s immunotherapy, Keytruda, for patients with the most common form of lung cancer whose tumors produce a specific biological marker. The FDA approval for Keytruda in advanced non-small cell... More »

FDA approves Bayer’s electronic autoinjector for MS therapy

The first electronic automatic injector to deliver a drug for the most common form of multiple sclerosis received approval from the U.S. Food and Drug Administration on Friday. The injection delivers Betaseron, a disease-modifying drug approved 22 years ago by... More »